Search results for Anti-Akt1

Anti-AKT1 antibody [AKT1/2552], Abcam, AB237994

Anti-AKT1 (phospho S473) antibody, Abcam, AB8932

Anti-AKT1 (phospho T34) antibody, Abcam, AB23509

Anti-AKT1 (phospho T342) antibody, Abcam, AB228808

Anti-AKT1/2 Antibody (R1U28), AntibodySystem, RHD96506

Anti-AKT1 Polyclonal Antibody (HB610014), abinScience, HB610014

Anti-AKT1 + AKT2 + AKT3 antibody [EPR16798], Abcam, AB179463

What is this antibody validated in? Anti-AKT1 + AKT2 + AKT3 antibody [EPR16798] (ab179463) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Flow Cytometry (Intra), Flow Cytometry (Flow Cyt), Immunoprecipitation (IP), Immunohistochemistry (IHC-P), Immunocytochemistry/immunofluorescence (ICC/IF) in Human, Mouse, Rat, Xenopus laevis, Xenopus tropicalis samples. What is the molecular weight of AKT1 + AKT2 + AKT3? Anti-AKT1 + AKT2 + AKT3 [EPR16798] (ab179463) specifically detects a band for AKT1 + AKT2 + AKT3 (UniProt: P31749) at a molecular weight of 56kDa. Trusted by the scientific community Anti-AKT1 + AKT2 + AKT3 [EPR16798] (ab179463) was first used in a scientific publication in 2014 and has been cited over 310 times in peer-reviewed journals. Trial sizes available! Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies. Other related products We have a range of other formats of antibody clone [EPR16798] also available for your convenience: ab179463, PE - ab210454 , Carrier free - ab214167 , Carrier free - ab271930 , Alexa Fluor® 647 - ab302553 Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-AKT1 + AKT2 + AKT3 antibody [EPR17671], Abcam, AB185633

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-AKT1 + AKT2 + AKT3 antibody [EPR17737], Abcam, AB200195

Patented technology Our RabMAb ® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb ® patents . What are the advantages of a recombinant monoclonal antibody? This product is a recombinant monoclonal antibody, which offers several advantages including: - High batch-to-batch consistency and reproducibility - Improved sensitivity and specificity - Long-term security of supply - Animal-free batch production For more information, read more on recombinant antibodies .

Anti-AKT1 (mutated E17K) antibody [RM336], Abcam, AB238304